PRRT3 and prostate carcinoma: Li et al. [33] revealed that silencing of lncRNA PRRT3-AS1 could activate the expression of the PPARγ gene and then block the mTOR signaling pathway to inhibit prostate cancer cell proliferation and promote apoptosis and autophagy.